Full Transcript Introductions and Personal Origins 0:07 Hi everyone. 0:08 I'm doctor Sanjeev Goyal and today I have Doctor Hans Vink and Bob along with me. 0:14 We're going to talk about this amazing new technology and, 0:18 a whole new science about the, 0:21 the endothelium. 0:22 This our micro vasculature of our of our body. 0:25 But before we get into that, maybe I just want to talk. 0:28 I wanted to ask them to introduce 0:30 a little bit about their history, how they got involved in this field. 0:34 Because I think it's quite interesting. 0:35 And, so go ahead, doctor Vink, please welcome. 0:38 And please tell us a little bit about how you got into this, this area of science. 0:44 Well, good afternoon or morning. 0:47 Or the goal. 0:48 Very nice to meet me. You'd be on your show. 0:51 Well, the way I get interested in this is really know. 0:54 A long time ago, more than 30 years ago, I started looking with big microscopes, 0:59 living tissues to to see with, you know, big magnifications, 1:03 how blood flows through the smallest vessels from the micro 1:06 circulation to through capillaries, where red cells flow through one by one. 1:11 And when I entered the field on the, 1:15 late 1980s, early 1:16 1990s, people for the first time realized that these small 1:20 little vessels almost appear empty is a big puzzle. 1:24 Why, only very few red blood cells are present in the small vessels? 1:29 Well, the estimates were that only 5% of the volume 1:32 of those small vessels were filled with red blood cells. 1:36 And it turned out, you know, to make a long story short, 1:40 that a lot of the low numbers of red cells and the dynamic changes in red 1:45 cell content are mediated by a transparent protective 1:49 protective gel called the glycol calyx that's inside these micro vessels. 1:53 So when I started this, my first, challenge was to identify 1:58 and find evidence of this transparent, elusive gel. 2:02 And then after a couple of decades, having imaging 2:05 technology developed to visualize the like, okay, let's 2:09 demonstrate. 2:09 It's important for microvascular health. 2:13 About that time, 2:14 I started developing a glycol checked medical device to measure the health 2:18 mica surface and glycoprotein in individuals at that time. 2:22 But in 2012, I met ball 2:25 when I'm working on a therapeutic based on dietary supplements 2:29 to increase the health of the like of calyx, and micro circulation. So. 2:35 So we formed a dye team to work on both the medical device 2:38 and the supplement together over the past decade already. 2:42 Okay, so that's a good point for Bob to jump in. 2:46 Well, thanks, Hans. 2:47 It's nice to be with you today. 2:50 My interest came really well, 2:53 my interest in the endothelial glycogen collection. 2:57 I didn't even know what it was. 2:59 In 2009, 3:02 I had a personal health scare. 3:06 I, I was traveling all over the world. 3:08 We had a large automation and controlled business, and then we ended up selling it. 3:15 To the largest, 3:17 electrical device company in the world in France, Le Grand. 3:20 So I had, some time and some money on my hands, 3:24 but in building that company, I had been traveling around the world 3:28 quite a bit and really burning the candle at both ends. 3:30 And where I live is kind of up in the mountains in Utah. 3:35 And when I would hike, 3:36 I would feel a kind of a tightness in my chest and that concern me. 3:41 I had been diagnosed as a type two diabetic probably a year before that. 3:46 And, you know, that's one of the early warning signs. 3:49 They tell you that, you know, that's going to lead to cardiovascular disease. 3:53 So when I went in for my annual physical, 3:56 I told my doctor, who's actually a personal friend of mine, but, you know, 4:00 I was experiencing and he said, well, you know, obviously that's not good. 4:03 I want to get you into a cardiologist. 4:06 So he immediately called a cardiologist that was a friend of his. 4:10 And he said, well, as luck would have it, he can see it today, 4:14 I want you to go down to the Utah Valley Regional Medical Center and see him. 4:19 So, you know, I was like 9:00 in the morning. 4:21 So I figured out, I'll buzz down 4:23 there, I'll talk to him for a few minutes and I'll be on my merry way. 4:26 Well, that's not what happened at all. 4:28 So he came in and talked to me with his, physicians assistants. 4:32 They got my medical history. Check me out. 4:35 Took my blood pressure, did all the normal things, 4:38 and then they said, well, probably be the reason you're having that 4:42 tightness in your chest is you've probably got a blockage in one of your arteries. 4:47 And, you know, 4:49 I'm the reason I'm here at the hospital 4:51 today is I'm in the cath lab and I'm doing, angioplasty. 4:55 And, we're putting stents in patients. 4:58 So explain that process to me. 5:00 And he said what I really think we need to do. 5:03 And they came in and did some preliminary testing 5:05 and they said, you know, we don't know for sure. 5:07 The only way we can know for sure 5:08 is we're going with a little camera in your groin. 5:10 Back in those days, we'll go up in and we'll be able to see. 5:14 And if you have a blockage, we'll put a stent in. 5:17 And so not at all what I was expecting to hear that day. 5:21 I hadn't had a heart attack. 5:23 There was no sign that I'd had a heart attack. 5:25 There was nothing in my blood. 5:27 He just wanted to do this as a precautionary thing. 5:31 And so bottom line is they did the procedure, 5:35 as the last procedure of the day because I wasn't in an emergency, of course. 5:39 And I still remember, you know, you're not completely out when they do that. 5:43 And I remember that really bright lights. 5:44 And I remember hearing the music really loud. 5:47 But then I remember when the cardiologist came in and they told me 5:50 so they I've got good news and I've got bad news. 5:53 What do you want to hear first? 5:54 And I said, don't tell me the good news. 5:55 And he goes, well, the good news is you didn't have any blockages. 5:59 We didn't have to put a stent in. 6:01 That's all. 6:02 That's great news. So what's the bad news? 6:05 And he goes, well, we don't really know what's wrong with 6:08 we don't know why you get that tightness in your chest. 6:12 And so then 6:13 he proceeded to write out, you know, some prescriptions, 6:17 blood thinner, hypertensive 6:20 meds, you know, 3 or 4 different things. 6:23 And then and I said to him, well, how long have I got to take these medicines? 6:27 And he says, well, probably the rest of your life.
What the Glycocalyx Is and Why It Matters 6:30 And as I drove home that song, Kian. 6:35 And the more I thought about it, 6:37 I guess you could say in a way it made me mad 6:40 and it made me mad because they didn't really know what was wrong with me. 6:45 But yet they had done this what I would term an invasive procedure. 6:51 And in my my previous life, for 28 years 6:54 I had been in the financial services industry and I had built a very large 6:58 insurance and investment agency, and I knew what impact this procedure 7:03 would have on my future insure ability for health insurance and life insurance. 7:08 So I wasn't pleased that I had even done it, to be honest with you. 7:12 But then to find out I didn't have anything wrong with me 7:15 made me even matter. 7:16 And so we had just sold that company at the time. 7:20 And so as luck would have it, I had time and I had money, and I was really good 7:24 at looking up stuff on Google, and my radar was up really high 7:29 because I wanted to find out what was wrong with me, 7:32 because they couldn't tell me what was wrong with me. 7:34 And so, as luck would have it, 7:37 I started researching and I was introduced by a friend. 7:40 His brother was a doctor, and he had introduced me to some information. 7:45 That was what I came to learn. 7:47 It was had all been done by the science of doctor V. 7:51 And so I started reading and became and became, 7:54 I guess you could say, almost obsessed with trying to find out 12 7:58 or 13 years ago, all I could about the handle vaguely of like, okay, Alex. 8:03 And it was one of those things where the more I studied it, 8:07 I came to believe that was what was wrong with me. 8:11 But yet nobody knew about this. 8:13 And as I started reading some papers and stuff, I also got the idea, 8:18 and as I understood 8:19 more about the endothelial glycol collection, that it can break down. 8:23 And that's what leads to inflammation and all the things we've talked about on 8:27 your, 8:29 show today. But, 8:32 but basically, 8:33 it became clear to me that that was probably what was wrong with me. 8:37 And that's also probably what was wrong with millions of people 8:41 around the world that they had the same thing happening, 8:45 but nobody knew what it was and nobody knew how to diagnose it. 8:49 And nobody had a solution for it. 8:51 And so it was kind of, for me, 8:53 you might say, a lightning bolt moment in that, oh my gosh, 8:57 this could be the big thing 9:00 that you ought to really spend your time on. 9:03 And so I became an expert and I got the idea where I live in Utah, 9:07 most people don't know what 9:08 maybe they do is pretty much the nutraceutical capital of the world. 9:12 So there's a lot of nutraceuticals that are developed here. 9:16 And I have a lot of friends that had developed nutraceutical companies. 9:20 And even though that wasn't my primary interest 9:24 or what I've done previously, I had a lot of friends that had been in that industry 9:29 and had been very successful, and I personally had already 9:33 always taken supplements and tried to do the best that I could for my health. 9:37 So I was a big believer in natural products, you could say. 9:41 So I got the bright idea. 9:42 What if I could go out in the world because I believe 9:47 that God created everything on the earth for man's benefit? 9:51 And I thought, what if I could go out and find the plants or the sources 9:56 that you could take in your diet 9:59 that could restore and rebuild, 10:02 you're like, okay, surely they've got to be there. 10:05 And so the first tip I got was I looked at where, where are people in the world 10:11 the most healthy from cardiovascular killer events. 10:15 And, you know, you look at Japan, there's pockets in Japan. 10:18 And so I started looking in Japan and I became aware of that. 10:22 There was a type of seaweed that was available and that the Japanese consume. 10:29 And also I became aware that 10:31 this type of seaweed in an extract has some of the same characteristics. 10:37 Or it may be like what the glycol calyx is made of. 10:41 So that was my first tip, that maybe a type of seaweed or an extract of seaweed 10:47 might be important in restoring the glycol calyx. 10:52 The next area that I looked at 10:54 was the Mediterranean back in 2009. 10:57 The Mediterranean diet was a big, you know, here 11:01 everybody was talking about, you know, the reason they live longer 11:04 is because they eat a diet high in, 11:07 polyphenols and, you know, grape, you know, it's all organic. 11:11 It's all fresh fruits and vegetables. 11:15 And so I started looking at, 11:18 and I was introduced to a product that had just come on the market, and actually, 11:21 I was the first one to use it in the formula that I formulated, 11:26 and it was an extract of 27 fruits and vegetables. 11:30 And, the idea was that would be a super antioxidant. 11:34 And my thought with that was that it would stop the oxidative stress. 11:38 And so that was the first product that I ever developed, 11:41 and that was back in 2011. And 11:45 and so 11:46 at the same time, I had been reading all of Doctor Irving's papers 11:51 and I came to believe, he is 11:54 he's the guy that proved to the world what the glycol calyx even looks like. 11:57 And you can probably get him to show you some pictures on the show today. 12:01 But I got this bright idea because I was following him, 12:05 and I've read all of his papers and it published like 107 papers. 12:09 So I got the bright idea I could jump on a plane, I could go to the Netherlands. 12:13 And I knew he had just gotten the patent issued on this medical device. 12:18 It was a camera that you could put under your tongue. 12:21 And I thought, you know, rather than be an admiral, 12:24 he could tell me if I was on the right track. 12:27 And so that's what I did. 12:29 And that was about this time in 2012 12:33 that we met, and I went over and told him my health background, 12:37 and he said, well, you know, big American, 12:39 you guys love your cheeseburgers, your fries and your coke. 12:42 So don't expect that you're going to have a good score. 12:45 And so he tested himself and he got a really nice result. 12:48 See I'm just like a healthy 18 year old. 12:51 And then it was my turn to get measured. 12:53 And he measured me. And then, 12:56 he looked at it and he pointed at the screen. 12:58 And then they measured me again. 13:01 And then he was talking to the other guy 13:03 that was there in Dutch, and I said, well, what did you find? 13:07 Am I good or I'm bad? 13:08 And he said, I'm really confused. 13:10 He said, your results. 13:11 Not at all what I anticipated. 13:15 He said, your score is actually better than mine. 13:18 And that's not what I would have expected. 13:20 You and I hadn't told him up to our point, and we'd been meeting all day. 13:25 I hadn't been I hadn't told him we had been work. 13:28 I had been working with my team on a product. 13:32 And I said, well, what part of the real reason I came here today? 13:34 And I didn't tell you because I wanted to see, first of all, 13:37 what your device was in. 13:39 Second of all, I didn't want you to be biased. 13:41 I wanted you to test me without knowing what I was doing. 13:46 And, I created a all natural product that targets the glycol clicks. 13:54 And that's when he said, well, Bob, 13:56 do you realize, you know, up until now, I've spent my whole career. 14:00 I had to prove to the world that the glycol calix was real. 14:03 Then we had to figure out an imaging tool so we could measure it. 14:07 We had to figure out what its physiological function was in the body. 14:11 And then everybody always asked me the same thing, 14:14 because I can measure and I can get a score, 14:16 and I can tell them how big the glycol calyx is as a systemic organ. 14:20 But then they always ask me, so what do we do about it? 14:24 And, and he got a little emotional and he says, Bob, do you realize 14:27 I've tested drugs? 14:28 I've tested a whole bunch of stuff, and this is the first time that maybe, 14:33 maybe you've discovered this or what? 14:36 And so we started talking that day clear back in 2012, 14:40 and we decided that if we joined forces, we could both accelerate 14:45 what we were doing and bring something 14:47 totally special to the world that didn't exist. 14:51 And that would be an imaging device where we could 14:54 noninvasively measure a person and we could get a baseline score. 14:59 And not only could we tell them the systemic health of their endothelial 15:02 glycol calyx, but we could also tell them how 15:06 functional their micro circulation was. 15:09 So we started working together. 15:10 I actually became the CEO and managing partner of glycogen 15:14 at that time with Johns at the university. 15:17 And then we joined forces and, 15:22 worked on a new supplement based on the things he knew. 15:26 And we put our minds together. 15:28 And then we were able to use that, like, object to help us understand what worked. 15:33 And then we were able to use some scientific techniques he had used 15:37 for years to evaluate things and how they would affect the glycol calyx. 15:42 And that's how we came up with endo, the product that we offer now. 15:47 And we filed a patent on it that was issued in the US in 2018. 15:52 It's it's been issued in, Japan and South Korea 15:55 and soon bee interest, I think issued in Canada, for example, 15:59 European Union, China, all kinds of places. 16:02 So that's how we came together. 16:04 Kind of a long story, but I guess, 16:08 we your own health is a big motivator. 16:12 And if you want to make a difference, 16:13 you know, first of all, I wanted to fix myself. 16:16 But second of all, I knew this was a big hole 16:19 that nobody was focused on, and this was a story 16:22 that needed to come forth and be told to the world. 16:25 And that's why I convinced Doctor Vink to join me in this journey, 16:30 to not only bring these two products forward to edge, 16:33 but to educate the world on the importance of the micro circulation 16:38 and the role at the end of the of like the calyx. 16:40 So that's how we can maybe this is this is great. 16:43 I mean, I'm so glad you guys have met because you're really changing. 16:46 You're changing everything of our whole understanding of the micro vasculature. 16:50 So, doctor, doctor Vink, can you just tell our viewers, okay, 16:53 maybe in a lame person's term, what is the end of what is this like? 16:56 Okay, 16:58 what does it look like? 17:00 You know, why is it there? 17:02 What is it doing? Maybe show some pictures that would help. 17:04 Can I show a couple of slides? 17:06 Can you see my screen? 17:08 Yeah, it looks great. Okay. 17:10 Are you just a few slides? 17:11 Just first point I want to make clear. 17:14 You understand, is that most people, if they think about the vascular system, 17:19 they know the image on the left, they know the heart and the large 17:22 arteries taking a blood to the organs, and then all but the large veins 17:27 connecting the blood back to the heart, or what most people don't know. 17:30 If you take a microscope and look more closely, 17:34 you'll see that you know, close to any tissue cell in your body. 17:38 We have these microscope small vessels where the blood is really thick 17:42 and close to every tissue cell there where all the oxygen and nutrients 17:45 are being supplied to the tissue and where the waste products are collected. 17:50 So actually, 17:51 99% of all the contact area between 17:55 the vascular system and the tissue cells is in those small vessels. 17:59 Large vessels is only 1% of the total surface area. 18:03 Well, if you go into those small vessels, 18:06 what we realize now 18:09 and I'll come back to this little bit later. 18:11 So if you look at one of these individual small vessels, 18:15 you see the individual red blood cells going through it.
How GlycoCheck Measures Microvascular Health 18:18 Realize that in healthy small vessels, the red blood cells, 18:21 they never touch the inside of the festival. 18:24 There's always a significant gap between the surface of the vessel wall 18:29 and the center, where all the blood is flowing. 18:33 And so we wanted to know what's in between that space, 18:36 and then let me zoom in just a little bit more. 18:38 Just to give you an idea, 18:39 this is even larger magnification with an electron microscope. 18:43 Again, a cross section, one of those micro vessels. 18:46 Now you see here 18:48 a large magnification on top would be where the red cells are flowing. 18:51 This is the vessel wall. 18:53 And on top of the vessels 18:55 that the surface of the festival, you see all these bush like structures, 18:59 all these 19:00 blues like structures, all these hair sticking out. 19:03 It's a huge three dimensional mesh of all these hairs, which are polysaccharides 19:07 like heparin sulfate and hyaluronic acid that's being produced 19:11 by your endothelial cells at the line, the inside of your vessels. 19:15 And actually, 19:16 these bluish like hairlike structures, they bind a lot of plasma proteins. 19:20 And that's actually a lot of fluid forming a very stable gel. 19:25 And the gel, it's very thick, you know, it's ten times 19:27 thicker than the end, the film itself. 19:30 And it protects your endothelium. 19:33 And then make sure the cells don't touch the wall, don't stick 19:37 so you don't lose and you don't leak a lot of your proteins, 19:41 and you prevent inflammation and you prevent, coagulation disorders. 19:46 So, guys, that's, that's just to show you how it looks like. 19:51 And one more slide 19:53 is summarizing all 19:55 of the important functions that we have been able to study over 19:59 a couple of decades, with many other groups. 20:03 So on the left hand side, again, you see that 20:05 hair like structure forming a gel on the inside of your vessels. 20:10 And now we know that any function of your endothelium 20:13 that we know is important, like sensing how fast the blood is flowing 20:17 and telling your endothelium to stop producing nitric oxide. 20:20 What you need those polysaccharides 20:22 to tell the endothelium you need to start producing nitric oxide. 20:27 Also, the antioxidants that we know are important 20:30 to balance the oxygen radical levels, like superoxide dismutase. 20:36 They specifically bind to these polysaccharide structures of life. 20:39 Okay, so they need to be closed and bound to click okay. 20:42 Likes to capture the oxygen radicals that are produced little close to the vessel. 20:48 And then again, 20:49 leakage of plasma proteins and fluids is prevented by click okay. 20:53 And the same for red cells also blood platelets 20:56 and also the inflammatory cells, the leukocytes, the monocytes 21:00 they cannot touch and stick to the wall as long as there's a healthy 21:03 glycol exchange between. 21:05 So a healthy glycol to protect your vascular system and prevent all. 21:10 And make sure all these functions are preserved and prevents 21:14 unwanted coagulation and prevent unwanted 21:17 activation of your inflammatory system. 21:20 So that's it in a nutshell. 21:21 Yeah. So in essence corrosive. 21:23 You know, that's a very, important aspect. 21:27 You know, in larger vessels at the branching point of larger vessels, 21:31 you know, there's always the same spots over and over again. 21:34 We're SS corrosive starts, and we know exactly at those spots 21:38 because of the very complex flow profiles and those branch points, 21:42 there's very little glycolytic production goes like, okay, 21:45 production is stimulated by the forward motion of the blood flowing. 21:49 So those sites where F of corrosive starts 21:52 have a very thin like okay, compared to the rest of your vascular system 21:57 and those sites because of your very thin like okay, Alex, 22:00 you have the first sites where cholesterol will start leaking into your vessel wall 22:05 where platelet starts thick and causing coagulation problems where 22:09 leukocytes start sticking, causing an inflammatory problem. 22:13 That's where the lesions start growing, because that's a very defined area 22:17 with very small like acrylics, which make that part very vulnerable 22:21 compared to the rest of your vascular system. 22:24 And but in the microvascular 22:26 small capillaries is the same thing happening that we see in the big vessels. 22:30 Like are we also seeing like blockages or it's like what happens 22:35 what happens when the, glycol calyx gets damaged. 22:38 Yeah. 22:39 So, at the microvascular system way before you see, 22:43 problems in the larger vessels, when glycol calyx gets damaged 22:48 and it gets damaged by exposure to all the classical risk factors 22:52 that we know of, like smoking, 22:55 obesity, hypertension, elevated 22:58 glucose levels, elevated insulin levels or genetic predisposition. 23:03 So when glycosidic starts breaking down at the microvascular level, 23:08 a couple of things, start happening. 23:10 First of all, you start losing many of your small capillaries. 23:14 So very tiny spots of tissue will be deprived of access to capillaries. 23:20 And when metabolism goes up, those sites that are a little bit farther away from 23:24 the capillaries will get and they'll starve, 23:27 you know, micro like lots of tissue starving, building up over the years 23:31 and at some point will cause organ dysfunction. 23:34 But it takes years to build up. 23:36 And together with losing many capillaries and like okay, Alex's damaged 23:42 you also will lose is the dynamic response 23:45 of your microvascular system to changes in blood flow. 23:49 When we start exercising. 23:51 So if you have a healthy microvascular system, what the hell Steve. 23:54 Like, okay, Alex. 23:55 Well, if you start exercising and blood flow goes up to your muscles 23:59 at the same time, also, it's like, okay, the volume goes down, 24:02 allowing more blood volume to diffuse through more capillaries. 24:06 That's a much more efficient 24:08 delivery of nutrients and oxygen through your muscle cells. 24:12 So when Black organics breaks down, that dynamic response disappears. 24:16 So you have fewer capillaries and then blood flow goes up. 24:19 There's no matching increase in the blood volume at the microvascular level. 24:25 And no benefit for the increase in blood flow. 24:28 Because now the only thing that happens in a fixed number 24:31 of a small number of capillaries is that the flow goes just faster, 24:34 so the few capillaries that are left. 24:37 So at the very early stage, 24:38 being exposed to these risk factors, you lose many capillaries. 24:42 And the adaptive response to flow changes. 24:45 And you're causing all kinds of micro spots 24:48 in your tissues or tissue that will be dying. 24:52 And over years the organ function will be compromised. 24:55 But that doesn't show up in organ function until, you know, a 24:58 later stage when the damage is pretty, pretty damaging. 25:02 So how much early? 25:03 Like, let's say, you know, 25:04 I've heard about these studies where they autopsied, like, you know, at 25:06 18 years old and they saw already beginning of atherosclerosis happening, 25:11 like from your studies with the glycol check machine. 25:14 How early are we seeing changes in the glycol calyx? 25:18 Damage? 25:19 Very early. 25:20 We just completed a study, 900 healthy individuals. 25:24 There's an obesity study there. 25:26 We compared people with low risk to medium risk 25:30 to high risk based on their Framingham risk scores. 25:34 So, you know, taking into account whether they're smoking, their body size, 25:38 you know, the classical risk factors, but these people are still very healthy. 25:42 This is years before they will develop organ problems. 25:46 Already at this early stage, if we look at individuals, 25:49 with an estimated risk of cardiovascular event of 20% or higher 25:54 compared to a low risk group with less than 10% already at this early stage, 25:59 the high risk individuals lost about 50% of their smallest capillaries. 26:04 So this years before anything will show up in terms of a heart attack 26:08 or stroke or diabetes, 26:11 or other glycation disorders or inflammatory disorders. 26:14 So I'll say a decade, maybe two decades before the organs really start 26:19 this functioning. 26:20 You get major, major problems, early changes 26:24 at the microvascular level already show up, and it's gonna be identified. 26:27 And you can already be supported by, you know, 26:30 the products like both mentioned, like and. 26:32 Okay, Alex, specifically designed 26:35 to help the health and support the health of those capillaries at an early stage 26:39 before weight, years before the damage or cause organ dysfunctions. 26:44 So for let's we always heard and learn in medical school and all that. 26:47 Diabetes is a microvascular disease. 26:50 So is there an impact of these sugars 26:53 on the Glick okay Alex I'm just curious what's the connection there. 26:57 Yeah. 26:57 So, you know, it's at a very early stage or at early stage of type two diabetes 27:03 and the blood glucose levels go up and insulin levels go up already 27:07 at that stage before there is obvious vascular issues. 27:11 If you look at the micro vasculature, we see that both the high glucose 27:15 in combination with the high insulin cause a lot of glycogen looks damage. And 27:19 we see that you lose already know about 70 to 80% of your Michael vasculature. 27:25 You know, and the remaining capillaries are highly permeable. 27:29 But also you 27:30 lose the again, the, the the dynamic response. 27:34 So we know it's okay. 27:35 At the early stages, you lose a lot of capillaries. 27:37 But you keep infusing all of them all the time and keep your low 27:42 baseline levels at an acceptable level of number of perfused capillaries. 27:46 The soonest there's a meal challenge or an exercise challenge, 27:50 and metabolism goes up and blood flow goes up. 27:53 There's no matching increase in a number of blood perfused capillaries, 27:56 so block volume at the capital level stays constant at a low level. 28:01 And you know you start building up all kinds of issues all micro 28:05 spots in the heart, micro in the brain and the kidney will start being damaged. 28:10 And one of the interesting fields 28:14 that we have been studying for a long time is a diabetic kidney problems. 28:19 And we also see that in the kidney, the very early stage when glycogen 28:23 is damaged in the kidney, Michael vessels the glomerular capillaries.
EndoCalyx Supplement and Early Study Results 28:28 You see that like, okay, this is actually the determining factor 28:32 that prevents leakage of your albumin protein 28:35 out of the vascular space into the ordinary space. 28:39 And as soon as the albumin starts leaking, causes 28:41 damage to the capillaries and the filtration units. 28:45 So the common light in the kidney will they'll die one after the other. 28:49 And over years you start losing kidney function. 28:52 But as soon as you start noticing kidney function is compromised 28:56 already years of damage, behind you. 28:58 And, you know, then it's a challenge to get that back up, but up again 29:02 and, you know, try to stabilize 29:03 or improve your kidney function in those diabetic patients. 29:08 So I want to ask, Bob, you were the supplement and. 29:12 Okay. Alex, what is this? What is that? 29:15 Like, how successful is it with actually repairing? 29:18 Like, I imagine maybe preventing damage, but what is the studies looking like 29:22 with actually repairing? 29:23 Like, okay, Alex has been damaged for let's say years. 29:26 What is that? 29:27 What's the. 29:27 Well, that's that's a fantastic question because that's, you know, 29:31 that was my original target or goal was, you know, what, 29:36 if we could go out and find those natural compounds 29:40 and we could find him and put him in either, kind of extract rate 29:45 or make sure we had a good molecular weight that could get across. 29:49 And and by the way, there's a big like, okay, Alex, in your gut, 29:53 in your gut plays a big role 29:56 in your health is, you know, 29:59 you know, that's where 70% of your immune system takes place. 30:02 And that's also where the nutrients have to get processed. 30:06 But more importantly, they have to get across that 30:08 barrier in the gut, which is really a type of glycol collects. 30:12 And it's thicker, to get into the blood to get delivered in the first place. 30:18 And so that's what we spend a lot of time on. 30:20 And, we've actually done a lot of studies, 30:26 both maybe. 30:27 Hans, if you don't mind, you've got some really good slides, some pictures. 30:30 Maybe you could just show the results. 30:32 That might be the most useful thing to show you what we've been actually 30:37 been able to show, not only in, 30:42 dishes we can show. 30:43 We can immediately restore it. 30:45 We can show we restored, 30:48 take diabetes, diabetic mice, turn them in. 30:51 Take healthy mice. 30:52 Tournament, diabetic mice ruined their kidneys. 30:55 We can show we can restore their kidneys back. 30:57 And then we just finished a four year double blind placebo study 31:01 that the Dutch Kidney Foundation paid for. 31:04 And we can show you some results on that. 31:07 And then we've also been looking at know we published a big paper, 31:11 a month ago in, critical care on sepsis. 31:16 And, you know, in the fall, we published a big paper on Covid 19. 31:20 We're in the middle of this picks up this patient, and then we got this 31:23 onslaught of all these people with Covid that were coming into the ICU. 31:27 So we thought, well, let's see what's happening to these patients. 31:31 And, you know, sure enough, those sickest patients with Covid 19 31:36 lost up to 95% of their capillaries. 31:41 So they were worse than themselves, especially when someone's acutely 31:44 ill or has an acute trauma like an insult to the gut. 31:48 Okay. 31:48 Looks like you said smoking, perhaps a very bad high fatty meal 31:53 or an infection are these things that are transient, 31:57 and then the body comes back to 100% within six hours? 32:01 I'm just what is the what is the science on that? 32:03 Yeah, that's that's about the time course that we see happening. 32:06 If you have an acute challenge that's transient. 32:09 It takes about 6 to 8 hours. 32:12 To recover, let's say for a fatty meal or in the early days, we did some acute 32:16 challenges of inflammation and health insurance or smoking. 32:20 Let them smoke like five cigarets in an hour. 32:23 It was a very acute, 32:24 intense challenge that, you know, damages a lot of your clinical colleagues. 32:29 But, you know, 32:30 you're first of all, repairs and rebuilds, microfluidics by itself. 32:35 You know, if it has time enough to do that, it takes you about, you know, 32:39 six, seven, eight hours to do so, to take care of that. 32:43 If you're constantly exposed to challenges all the time, you know, 32:46 there's not enough time to rebuild and you all have chronic damage, 32:51 right? 32:51 And then infections, you know, they they attack the glycol calyx as well. 32:56 So like, I know, 32:59 you know, I've been I'm fortunate I have a glycol check 33:02 so I can test myself every day multiple times if I want. 33:07 But, you know, I developed a sinus infection. 33:10 I think it started as allergies, then went into a cold, but 33:13 ultimately evolved into a sinus infection. 33:16 And I could see it did, in fact, 33:19 impact like, like okay looks and my microvascular health score. 33:23 And I think that's part of the reason why you start to feel that systemic, you 33:28 still feel good everywhere in your brain starts to feel foggy, all that stuff. 33:31 So that's all related back to that infection was attacking 33:36 your lack of clicks. 33:37 In fact, Hans and I both noticed even just a simple thing 33:40 like going to our dentist and getting our teeth cleaned aggressively. 33:46 Later that day you could. 33:47 You'll even start to feel like you start to have flu like symptoms 33:51 because they've released all that bacteria. 33:54 That's an insult to your like, okay, let's and it takes a couple of days 33:59 for that to recover from even just that simple thing of cleaning your teeth. 34:02 Believe it or not. 34:04 Yeah, they do say that. Yeah. 34:05 After there's, like, bacteremia that occurs after, teeth cleaning. 34:09 Yeah. 34:09 It's like it's like this massive release of all this bacteria. 34:12 Right. 34:14 So if I did, you want to show maybe some stuff. 34:16 Just answer this question. 34:17 Yeah, sure. 34:18 I can show a few data slides on how and would that be 34:21 healthy first, like Felix and maybe if it's okay. 34:25 Can I also show it? 34:27 Yeah, it could also show a little more couple of minute 34:29 video to explain how we do the measurement with it, like a check device. 34:34 All right, all right, there we go. 34:36 Hold on. 34:38 So first a little bit about the climate check system 34:40 how it measures the health of the like vascular system. 34:47 What's your health score. 34:49 The score that identifies 34:50 if you're at greater risk of the most troubling diseases and conditions. 34:54 The score that signals that these diseases and conditions 34:58 may be silently developing inside your body. 35:01 The score that will help you understand how your body is alerting 35:05 you with several early warning signs. 35:09 For the first time, you're able to get an overall health score 35:12 with a new, simple and noninvasive test called glycol Check. 35:16 It's a new patented technology, 35:18 and the tests can be easily performed in a health care practitioner's office. 35:22 Glycol check gives you and your health care provider the one single number. 35:26 A microvascular health score that alerts you in trouble could be lurking 35:30 deep inside your capillaries. 35:32 The good news is that 35:33 even if you have a poor score, you can easily improve your health. 35:38 While you may look healthy on the outside inside your microvascular system, 35:42 a completely different situation could be unfolding 35:45 with the discovery of a transparent 35:47 lining in your capillaries, called the glycol calyx. 35:50 Your health could be declining because that lining may be breaking down 35:54 and becoming leaky, 35:56 which can contribute to the advancement of many diseases that develop over time. 36:00 Aging, poor diet, lack of exercise, genetics, 36:03 stress, and smoking can cause the glycol calyx to break down. 36:07 In the past, there hasn't been a way to peer deep 36:10 inside the microvascular system to observe the breakdown of the glycol calyx. 36:14 But now, for the first time, with glycol, check, it's possible 36:18 to see live movement of red blood cells as they travel through micro vessels. 36:22 Glycol check was created out of the need to measure the microvascular system 36:26 by world renowned researcher Doctor Hans Fink. 36:29 Doctor Vink began his intense study of the glycol calyx in 1989. 36:33 Over the years, he has received many research grants and prestigious 36:36 awards, all focused on the discovery and breakthrough understanding 36:40 about the importance and clinical implications of the glycol calyx. 36:44 He has authored or contribute to hundreds of scholarly papers and reviews. 36:49 Glycol check works by simply placing a video microscope under the tongue 36:53 for a few moments to video, record, analyze, 36:55 and objectively report a single overall microvascular health score. 37:01 Glycol check counts the 37:02 number of blood vessels and capillaries and measures red blood flow concentration. 37:06 It also measures flow rate and different how 37:09 deeply the blood cells penetrate into the protective glycol calyx. 37:12 Gel lining, a sign of deterioration. 37:15 Glycol check combines all these important measurements 37:18 together to generate a single systemic microvascular health score. 37:22 Lower scores indicate greater risk to the health of your organs. 37:26 As the test is becoming more available, 37:29 it can be administered in a health care practitioner's office. 37:32 Each test includes a baseline score and video of the microvascular blood flow, 37:36 and tracks how over time, the microvascular score declines 37:40 with health deterioration or improves with therapy. 37:43 Today, there are more than 85 ongoing clinical studies in locations worldwide 37:48 such as Duke University, University of Pittsburgh Medical Center, 37:52 VA Hospital of Salt Lake City Children's Hospital in Philadelphia, 37:56 the University of Oxford, Harvard Beth Israel, Leiden University Medical Center, 38:01 Steinhardt Diabetes Center, University of Exeter, and dozens more. 38:06 These respected research centers are all using glycol check 38:09 to confirm that a damaged glycol 38:11 calyx contributes to several diseases and conditions, as well as the resulting 38:15 complications from diabetes, stroke, septic shock, obesity, 38:19 cardiovascular disease, hypertension and other diseases with glycol. 38:24 Check now you can be tested and get the score that reveals 38:27 the overall health of your microvascular system. 38:30 With the results of your test, you will be in a better position to apply 38:33 therapies and nutrition that can improve your microvascular health score. 38:38 For more details about glycol, check. 38:41 Well, I guess that was a good introduction. 38:43 How we measure with the camera. 38:45 Now we get all these live, live images. 38:48 And based on that, 38:49 we can measure, you know, the health of your micro vasculature. 38:52 How degrades by being exposed to risk factors and how the, the clicks 38:57 therapeutic can help you to improve the health of your micro vasculature. 39:02 So just a few things about the supplement. 39:04 It's a patented supplements. Actually. 39:06 We've got a methods ethanol method on that. 39:10 And mechanics is actually a composition 39:13 and a treatment method to improve the health of your endothelial tank. 39:16 Okay, Alex. 39:18 And as we 39:19 discussed, it basically consists of three main compounds. 39:23 So we have the polysaccharides that are in the seaweeds that are almost identical 39:28 to the polysaccharides in those hair like, which like structures of glycol calyx. 39:32 So they will immediately fill in the holes in a damaged leg. 39:36 Okay, Alex. 39:37 And also scavenge, important enzymes that bind to the polysaccharides. 39:42 And you can prevent those enzymes to break down like a calyx even further. 39:48 We've also mentioned we have the antioxidants. 39:50 It's specific antioxidants that bind to, like, okay, Alex. 39:54 And scavenge radicals and prevent further damage. 39:57 And then the third compound is high dosages of glucosamine, 40:00 because we now know that glucosamine is a rate limiting, substrate 40:04 for the endothelium to produce more like okay, Alex. 40:08 So with that, 40:10 you know, we did several tests and studies. 40:12 This is just an early study showing if you measure 40:15 the level of glycol helix damage, 40:18 before and after taking, starting taking. And. 40:21 Okay, Alex, you can actually monitor very closely how the level of like, 40:25 okay, Alex diminishes in response to taking in the calyx. 40:30 Another acute study, was on the, 40:34 protective effects against acute inflammatory challenges. 40:38 So if you look, the vascular system 40:41 and we infused this is a smaller venue and we infuse every few seconds 40:48 saline solution, you flush out the blood and you can see in the background 40:52 those little transparent cells, which are the inflammatory cells. 40:56 And as long as they're rolling, 40:58 they they're good or they're checking whether the festival's healthy. 41:02 But, you know, as soon as they think there is a damage 41:04 and then they stop rolling, they stick to the wall, 41:07 and that's causing the local inflammation. 41:10 Now, if we 41:10 count the increase in level of inflammation by counting 41:14 the number of sticking, inflammatory cells to the wall in response to a challenge, 41:20 or you see the, the red columns show in the untreated vessel, 41:25 if you damage the medical vasculature by breaking down, click okay, Alex, 41:30 that, you know, within 30 minutes, there's about a 300% 41:33 increase in the level of inflammation. 41:36 Well, if you take and okay, Alex, it protects your vasculature. 41:40 And even though there's a slight initial increase in the level of inflammation 41:44 upon the acute challenge, it can fully protect your vascular system. 41:48 And you're like, okay, against further inflammatory, damage in an acute setting. 41:54 Well, we have 41:56 the example, of, 41:58 you know, study that we're doing in kidney patients. 42:01 This is the same kidney patient before and after taking. 42:06 And okay, Alex, for four months. 42:09 So you don't need a lot of computing to see on the left. 42:12 Oh, you have very few capillaries. 42:14 And there's very low level of blood flow, 42:16 a low blood volume in the micro vasculature. 42:18 After four months, there's a very significant increase 42:21 in the number of capillaries and the level of blood flow in the micro 42:24 vasculature, as an example, that actually new capillaries are formed. 42:29 I mean, we kind of 42:30 used to think this or is it just that existing capillaries are opened up? 42:34 Well, no, it's actually in this stage, there's a, this balance 42:38 between the production of more new capillaries and, and the breakdown. 42:42 So you have a very low number of capillaries all the time, 42:45 because the breakdown goes faster than making new ones. 42:49 And what the end. 42:50 Okay, Alex does and by rebuilding your work like okay, it protects 42:54 the existing capillaries against breakdown. 42:57 So there's more time to make more new capillaries. 42:59 And you shift the balance towards more capillaries being produced 43:03 and surviving longer. 43:05 And, so the net effect is that you will have more new capillaries 43:09 that stay healthy and functional for a longer time. 43:13 So the balance is more towards more production of new capillaries. 43:17 Instead of, you know, breaking down the existing complex to fast. 43:21 So it's this new capillaries, and actually by making more new capillaries, 43:26 you also will have the, the, the luxury 43:29 to have a few of those capillaries not being used at all times. 43:32 So you can also build up the reserve capacity. 43:35 So, you know, if you have only a few capillaries, 43:37 you don't have a reserve capacity. 43:38 You use them all the time. 43:40 All the capillaries you have, if you build more capillaries, 43:44 well at baseline conditions you will have more capillaries and more blood flow. 43:48 You will also be inside exercising or metabolism increases for different reason. 43:53 You have a reserve number of caterpillars that you can actually recruit 43:57 when necessary. 43:58 So both are happening after the, and okay, Alex, therapeutic. 44:03 Well, this is just showing also in the same individual, 44:07 if you look at your microvascular health,
Clinical Applications in Kidney Disease, Wounds, and Blood Pressure 44:10 that individual started with a low Michael faster health score. 44:13 And after three months, the score was going up. 44:16 Then he ran out of product. 44:18 So he stopped taking the therapeutic score, went down again, 44:22 and then a second time again. 44:23 After two, three months, the score went up significantly as a result of rebuilding. 44:27 Look like okay, Alex. 44:28 And getting higher numbers of capillaries. 44:31 Now at the same time, 44:32 we were able to measure kidney function in the same individual and showing 44:36 that this individual started out with a very low level of kidney function. 44:40 So this is the filtration rate and the filtration rate in milliliters per minute. 44:46 So this 30 meals per minute is the low end 44:48 you know close to complete kidney dysfunction. 44:52 And again with rebuilding your microvascular function improved 44:55 and went down again when the patients stopped taking the therapeutic. 44:59 And then the second time or filtration rates went up to 7080 meals per minute. 45:05 So the not only is stabilized this is incredible. 45:08 So this actually triggered a lot of support from the kidney Foundation 45:12 and the Dutch government, supporting a large clinical trial that we just completed. 45:17 To see also earlier stages of kidney damage, 45:21 if we could stabilize and prevent the real breakdown of kidney function. 45:27 But this was a patient. 45:28 But then it got trial been completed. The newest. 45:30 The new. 45:31 The clinical trial has been completed. 45:34 The data has been analyzed. 45:35 The paper is being finalized, 45:38 so it'll take it a little bit longer for the paper to come out. 45:42 But, you know, 45:43 we are very happy about the results, so I cannot share too many details yet. 45:47 But, you know, we're very hopeful 45:49 at early stage that the therapeutic is very effective 45:53 in protecting and improving the health of your micro vasculature. 45:57 Well, just the same for everybody. Sorry. 45:59 Just jump in there quick. 46:00 Well, no, that's a good question. 46:02 So the, the good thing 46:03 about using the classic device, we all start out with the same dosage, 46:09 but you can actually monitor 46:10 the effect on your microvascular health and you can increase the dosage. 46:14 You need, you know, a more potent, therapeutic. 46:18 So the baseline, dosage is about four capsules a day. 46:22 If people are really compromised, we advise to start with eight capsules a day, 46:27 and we actually, we can monitor how effective the increase in microvascular 46:30 health is depending on the dosage and the challenge you are facing. 46:34 This is just another example. 46:35 This is a person with a diabetic ulcer 46:39 showing an open skin wound in the lower limb that didn't heal. 46:42 And you know the you see the tissue color changing and becoming really dark 46:47 and all blood perfusion in the wound and the lower limbus 46:50 getting very close to being amputate it. 46:53 You know, starting taking in the calyx already. 46:56 After a few weeks, you see that the, the color of the tissue inside a wound 47:00 starts increasing, showing more blood perfusion, more reddish color. 47:04 And after 3 to 4 months, it's complete recovery and the wound started to closing. 47:09 Well, an additional observation that it's consistent in many other case studies 47:14 is that this individual had an untreatable level of, 47:17 hypertension of 200 to over 110. 47:21 All the conventional therapeutics did not have any impact on the blood pressure. 47:26 And within a couple of weeks, we noticed and we were doing a lot of follow up 47:30 studies right now on the hypotensive effects, blood pressure normalized 47:35 within weeks, 226 over 70 47:38 and stayed constant consistently at the normal level. 47:42 Just to follow up, we did some animal studies, 47:45 which I'm going to show you some of the results. 47:48 So comparing, you know, in mice now young mice to all the mice. 47:52 And you know with aging you lose a lot of your medical vasculature 47:56 and a lot of damage to your glycogen helix. 47:58 So the microvascular health score goes really down. 48:02 And you know, the same old mice taken 48:04 for eight weeks, you already saw a very significant improvement. 48:08 The microvascular health, 48:10 in these animals you see also with nitric 48:12 oxide production goes down with aging. 48:15 And actually within eight weeks, 48:18 increases to a almost normal young mouse level. 48:22 This is, gut inflammation that, nitrous oxide. 48:26 How does the, glycol clicks increase? 48:29 Nitric oxide? Can you just help explain to me? 48:32 Well, what is it really? Yeah. 48:33 One important, mechanism by which your your own 48:37 Michael vasculature and you're in the cilium 48:41 is triggered to produce more nitric oxide is by being able 48:44 how blood flows over the service of your endothelium. 48:49 So if, if healthy and the thallium 48:51 blood flow goes up in the cilium, senses, the increase in blood flow, 48:56 and then like, okay, let's tell your endothelium to start 48:59 producing more nitric oxide to dilate 49:02 and make sure the shear forces there do not get too high. 49:07 Well, you need a healthy like okay. 49:08 Like for that it's like okay. It breaks down. 49:10 Both flow can be really fast, but you're and the ceiling doesn't sense. 49:14 It doesn't produce nitric oxide. 49:16 So by rebuilding you're like okay. 49:18 Like you rebuilt the sensor when you first of all to detect changes in blood flow 49:23 and failure in the cilium to produce more of your endogenous, 49:27 nitric oxide levels. 49:29 So that's, you know, that's what this. 49:31 Yeah, sure. 49:32 Go hard question on that is about the respiratory system. 49:35 Is there any connection I need to mention the gut. 49:38 But with the cilia of the respiratory system like this. 49:43 Like okay Alex, is there something similar happening. 49:47 Well. 49:48 And system no, it's it's similar to the cilia. 49:52 Also, our shear stress responses, 49:56 and a few studies that I was part of. 49:58 It's a long time ago 49:59 we noticed that the cilia are actually had sides of very low shear stress 50:04 and think like, okay, so they are able at those sites to sense of shear stress. 50:08 But the other side where there's high levels of shear stress 50:12 like okay, legs will be abundant and covering the cilia 50:16 and acting as the main shear stress sensors. 50:18 So they, they, they, they team up to take care of 50:21 both the low shear and the high shear regions to make sure you're and the cilium 50:26 actually is able to respond to the shear stress changes. 50:30 Well, a few more on this to, to get back to you. 50:32 So, improvement of nitric oxide 50:35 in older mice with the improvement of aerobic acrylics. 50:40 Also the, the gut inflammation levels. 50:43 So we measured the accumulation of inflammatory cells in the gut 50:47 goes up significantly with aging by repairing your 50:51 microvascular and gut like, okay, links and all those levels of inflammation 50:55 go back to normal, low levels, as in the young mice, 50:59 similar as in that one patient with the skin issues. 51:03 We see that in the mice our blood pressure drops by 25%. 51:07 Yeah. 51:07 In old compared to almost within the calyx. 51:11 And we are doing some pilot data which we have been collecting in humans. 51:16 So these are just voluntary case reports of individuals with hypertension 51:20 showing how they respond to click. 51:22 Okay. Alex. 51:23 So all these are just averages of a few of those case reports. 51:27 So systolic blood pressure is going down from under 65 51:30 to 125 just in weeks. 51:33 Similarly for diastolic pressure is going up going down from 100 51:39 something to two, close to 7580 mils, millimeters of mercury. 51:44 So okay with that? 51:47 Well, I'll just show you 1 or 2 more just to finish up this. 51:50 This is just a a proof of concept study that we did, 51:54 early on when we were developing the and okay, Alex. 51:57 So these are healthy individuals for a section of the general population. 52:01 So that baseline, we normalized 52:04 their microvascular health at the hundred percent and over time. 52:08 So this is after two, three, four months, you see very significant improvement, 52:12 a 50 or 60% improvement of their microvascular health. 52:15 And still, increasing. 52:17 It's not plateauing yet. 52:19 So we are we we designed the study to stop after 3 or 4 months. 52:23 But as you can tell now, the longer you taken. 52:25 Okay, Alex, the better the improvement of your microvascular health will be. 52:30 We think we think that, I mean, Covid, 52:34 the death is caused by poor oxygenation, hypoxia of tissues. 52:38 Right. 52:38 So is it not potential that the end to end. 52:42 Okay. 52:42 Alex, could be helpful in the acute phase of oh yeah, you're you're spot on. 52:46 It's almost like we shared my slides already with you before So we just 52:50 we just finished, very, very exciting studies on Covid patients. 52:56 And as people have been reporting, we actually could confirm 52:59 that Covid really, hits your Michael vascular system. 53:03 So we looked at Covid patients in the ICU and compared, 53:08 relatively healthy Covid patients that did not need mechanical ventilation 53:12 with, really sick patients that are on mechanical ventilator. 53:16 We show Daniel, the ones on the mechanical ventilator, 53:19 they lose already up to 95% of their Michael fast picture 53:24 and their usage levels, of, like, acrylic damage. 53:29 And if you measure 53:30 the level of, like, Felix damage, 53:33 it perfectly predicts the outcome of these individual patients in the ICU. 53:38 So ones with the relatively healthy Michael vasculature and look like Felix. 53:42 If we do follow ups in the ICU, 100% of them survive. 53:46 The ones with the really significant damage of glycogen to Michael vasculature, 53:50 the longer they stay in the ICU, the smaller their chance of survival. 53:55 And, correlates very closely with the number of organs failing 53:59 not only the lung, but the kidney, the brain, the heart, very similar. 54:03 There's another study that we did on sepsis patients. 54:06 So the more damage to your Michael vasculature and kidney, 54:09 the more organs will be affected and start breaking down. 54:13 So again, the next step obviously would be to test would and okay, Alex, 54:18 you know, as early as possible can help you protect against the virus 54:23 attacking your endothelium and breaking down your like acrylics. 54:26 So we are actually, as we speak, designing a huge international trial. 54:31 Do as soon as people get a positive test to see if we can actually help them 54:35 protect that Michael fast, Richard, from breaking down, 54:38 but also and maybe even a more important people that actually, 54:44 are cured from the infection. 54:46 You know, I know many of them, for many months later, 54:50 all kinds of complications, 54:53 Covid syndrome. 54:54 I had a patient just tell me. 54:56 Yeah. Two months. He's still feeling unwell. 54:58 Yeah, yeah. 54:59 So we see we have, look, with the lack of check system 55:02 and quite a few of these, people recovering from Covid. 55:07 Yeah. 55:07 And there's a huge level of microvascular damage. 55:09 So you can imagine if all your couples break down. 55:12 Oh, your, your fatigue increases, your kidney function goes down. 55:16 So high risk of heart attacks and brain issues. 55:19 So very looking like forward also on the longer term 55:22 to see if we can help these individuals repair and rebuild the micro vasculature, 55:27 if we can help them recover much faster from that challenge. 55:31 Wow, my mind is blown. 55:33 But I want to come back to Bob. 55:34 I mean, I asked that question about the omega three, 55:36 and now I think I may have an answer myself, but I want to I want to hear what 55:39 your thoughts about this. 55:42 Well, 55:43 you know, I mentioned to you that I've always taken lots of supplements, 55:46 and so I've been taking omega threes for a very long time.
COVID, Sepsis, and Future Consumer Access 55:50 When I had my situation. 55:52 And so, 55:55 from what I can tell, 55:57 testing with the I could check and I've tested, you know, 56:00 lots of people to get their baseline score that take omegas. 56:04 I don't think Omegas target specifically what we're targeting. 56:09 Yeah. 56:09 With the end up killing supplement. 56:13 So you know that there's still, you know, there's lots of studies and there's 56:17 lots of things that talk about omegas, 56:20 but from from my from my view. 56:24 And I've tested lots of people, you know, with 56:28 lots of different types of omegas that they've taken. 56:31 And I don't see that it makes a significant difference 56:36 in their microvascular health score 56:38 or more importantly, in their, 56:41 microvascular density or the thickness of their glycol calyx. 56:46 And so that's that's what's so unique 56:49 about what we created is we're targeting specifically 56:55 this function in the body, and we know what causes it to break down. 57:00 And so we had to go find those ingredients 57:03 and make sure that they could be absorbed. 57:05 And then they're targeted to do a specific thing as Hohns was explaining to you. 57:10 So even in talked a little bit about the antioxidants 57:14 that we put in, but the seaweed that we chose actually. 57:20 You know, what happens is happened is one of the enzymes 57:23 that actually attacks and breaks down the glycol calyx. 57:26 Well, what we've learned as part of this four year study 57:30 that we just completed with and okay, Alex and kidney 57:33 patients is doing the pharmacological analysis both. 57:36 And we did it in animals. In humans. 57:39 We learned that, 57:41 it's 100% heparin Ace inhibitor. 57:44 So not only are we restoring the okay, let's 57:48 the dose level that we've got stays in the blood. 57:51 And it is a 100% help relationship. 57:53 Bitter which prevents the glycol collects from breaking down. 57:57 So you know the mechanism of action. 58:00 That's why we were able to get the patent. 58:02 It's the synergistic action of the compounds working together 58:07 as a method to treat and restore the endothelium. 58:10 Like okay. So that answer your question. 58:13 You know, that doesn't I think what I, 58:15 you know, people think that it looks like like the import of the seaweed. 58:19 I'm thinking about an a diet perspective now 58:22 apart from the supplement is that we sometimes take this. 58:25 We think it's one aspect of, let's say marine food that would be healthy, 58:31 but it looks like there's so much more that we don't understand 58:34 and that there's so much that we don't understand. 58:36 And we've been on this journey together, since 2012. 58:41 And what I tell people is, you know, we really feel like we're Lewis and Clark, 58:46 and we, we left on a journey from, you know, the middle part. 58:49 And we're trying to find where's the Pacific Ocean. 58:52 You don't know what's in between. 58:53 And so, you know, the benefit we've had is we've been able to put the 58:57 like a jack into, you know, well over 59:00 125 academic research hospitals. 59:04 And then we collaborate and we've gotten all of this research data 59:09 on pretty much any condition or disease you can think about in the body. 59:13 And that's what we spent the last ten years doing, is getting all of this, 59:19 reserve of information to 59:21 clearly show when the, like, okay, like it breaks down, 59:25 that it leads to a breakdown in the density 59:29 or the number of capillaries you have, which then starts 59:32 that spiral of organ starvation. 59:36 And so, you know, if I had a dollar for every doctor 59:39 that it told me, man, if I would, if I could have had this 59:42 the last time I've been wishing I had a device like this, 59:46 because it would be so nice to see what's happening to a patient 59:49 before they show up in the ICU with a heart attack or stroke. 59:53 But you know, there was no way to know. 59:56 And so this is it's really the canary in the coal mine 1:00:00 that's going to give a health practitioner 1:00:02 a much better idea about what's happening. 1:00:06 And as you say, it's very complex. It's not. 1:00:08 The diet has an impact. 1:00:10 One of the early studies that we did, 1:00:12 we did a study just because we wanted to see the impact of food. 1:00:16 So we we did. 1:00:18 We had the group of people all eat the same diet. 1:00:22 And then we fed them a high fat, high sugar meal. 1:00:26 We gave them a quarter pounder, a large fry and a large Coke. 1:00:31 And that's that's what happened. 1:00:32 And then we tracked the people and different people. 1:00:36 They recovered different time frames 1:00:39 from that high fat, high sugar challenge. 1:00:41 But, you know, that's where we learned that the average recovery time is, 1:00:45 you know, five to maybe some people took longer than eight hours. 1:00:49 And, you know, that was an indication as we were validating 1:00:53 that their microvascular health was poor. 1:00:56 But then it was validated even by how the food they ate was processed. 1:01:01 You know, so things like, you know, Hans talked about exercise, 1:01:04 all the things that you talk to your patients about. 1:01:08 Everything has an impact 1:01:09 on the, you know, even the altitude, the air we breathe. 1:01:13 You know, we've even had people take it like a check up to very high altitudes. 1:01:19 And to see what effect altitude has, I'm like, okay, so, 1:01:22 I mean, everything you can think about has an impact on this internal regulate. 1:01:27 It is the largest organ in your body. 1:01:30 If you stop and think about it and it's it 1:01:33 regulates all kinds of stuff. 1:01:36 You know, it's another thing you think about 1:01:39 how how the body communicates its negative and positive charges. 1:01:42 You know, well, the glycol collects as a negative charge. 1:01:46 It's the grounding mechanism for the body, for example. 1:01:51 And so that's why you got to have a really strong like, okay, let's just you know, 1:01:55 you know, what happens in a house if you, if it's not grounded, you get sine 1:01:59 waves and all kinds of miscommunication and burn up motors and all kinds of stuff. 1:02:06 So okay. 1:02:07 That's you know this is amazing. 1:02:08 Again I think this will open up a whole new world for me and the viewers. 1:02:12 Where can they go to learn more about the glycol check. 1:02:17 I mean this is obviously something that's in doctors offices 1:02:20 or research institutes and the supplement and. 1:02:23 Okay. Looks well, 1:02:26 so glycol check. 1:02:29 Until just recently, we only offered it 1:02:31 to, research hospitals, but we're just now coming out 1:02:36 with a version that will be offered to medical clinics like yours. 1:02:40 And you're fortunate I put you on the list so you'll be one of the first ones 1:02:44 to receive one. 1:02:45 But, they can go to glycol check.com, so it's just like it 1:02:50 sounds glycol 1:02:54 ecom glycol check.com. 1:02:57 And there's videos and we explain. 1:02:59 And if they want to do a deep dive if you've got doctors listening in there's 1:03:04 I think over 70 I don't know what we're up to 75 or 6 peer 1:03:10 reviewed published papers across across a wide range of diseases, all, 1:03:16 showing you the the impact of a decreased, 1:03:19 microvascular system and that microvascular health score. 1:03:23 The other place they can go to to learn about endo calyx 1:03:27 would be to go to, microvascular.com. 1:03:33 And that's the website there. 1:03:35 And we offer 1:03:38 endo collects there. 1:03:40 And then I know you're located in Canada 1:03:43 and we just now are getting the supplement. 1:03:47 You have to get it approved so we can import it into Canada. 1:03:50 And I think by the end of the month, I'm hopeful we'll be approved in Canada. 1:03:55 And then it will be available from, physicians like you and me. 1:03:59 And then we have an auto fulfillment program. 1:04:02 They can buy it when they come into your office. 1:04:04 You can put it on your website, 1:04:05 and they can sign up for autoship and will fulfill it from our warehouse in Canada. 1:04:11 You know, that's that's amazing. 1:04:13 When to consumer when to consumer device coming for Geico check. 1:04:16 Is that coming 1:04:17 because I can just imagine that one would want to be able 1:04:20 to check this all the time and see the impact because they, 1:04:23 you know, why wait for the doctor once a year? 1:04:25 I would that'd be quite difficult. 1:04:26 No. So you're you're you've read my mind. 1:04:29 So the first thing we had to do is we had to get all the validation 1:04:32 and the clinical studies, and then we needed to bring it to the doctors. 1:04:36 So it's following along the same path that, you know, blood pressure cuffs 1:04:40 or glucose meters 1:04:41 or a lot of the things that were originally done in the doctor's office. 1:04:45 Now consumers don't want to know, and there's a lot of them can do 1:04:48 it in their home. So, 1:04:51 what we're doing right now is we're taking our software 1:04:53 and we're putting it up into the cloud, so it becomes software as a service. 1:04:58 And then all of that data will be stored up there on a HIPAA compliant way 1:05:03 to protect the privacy. And, 1:05:07 and then the new 1:05:09 we have a brand new camera that you'll be one of the first recipients of. 1:05:13 And then we're working on a consumer version of that camera 1:05:18 and an app, and then people will be able 1:05:21 to use their smartphone as the, screen 1:05:26 to see, you know, that what you saw on the screen, 1:05:29 you'll be able to see that on your phone, and then you'll be able 1:05:32 to send it up to the cloud. 1:05:34 And in a few minutes, we'll send you back a report, 1:05:37 and then we'll have an app and it can mesh. 1:05:40 We'll have to work to 1:05:42 mesh with all the other health apps that you have on your phone. 1:05:44 But you're absolutely right. 1:05:46 This is going to have an impact on consumers because, 1:05:50 there's a lot of people that track the blood pressure. 1:05:53 They track their glucose levels, they track their, 1:05:56 you know, they track their cardio, you know, variable heart rate. 1:05:59 You know, I track all these things myself with my smartwatch. 1:06:02 And then I've got a couple other little things I do. 1:06:05 You know, I want to know what's happening to me. 1:06:08 And so this is one of the key elements. 1:06:10 And so you're very intuitive. 1:06:13 I think this will become a part of every person's annual physical. 1:06:18 It's just as important, maybe more important, 1:06:20 to know this than even your glucose level and your blood pressure, 1:06:24 because this is what's implicated in what's happening in those two areas. 1:06:28 Right. But then, 1:06:31 it the other thing, it's it's a huge opportunity 1:06:34 is when it comes to peak performance and health performance in individuals. 1:06:40 So we have actually tested the professional endurance athletes. 1:06:44 And there's a huge difference that we can measure 1:06:47 even in the function of their endothelial glycol. 1:06:50 And that's going to impact how well they can the oxygen level. 1:06:54 What's going to affect what's happening to the muscles when they get under stress. 1:06:58 And it also has a big impact on their recovery time. 1:07:02 You know, how stiff they get and how quick they can get back to action. 1:07:05 Because not only are we delivering all the nutrients, the oxygen 1:07:09 and hormones, you think about it, we're moving all the waste in the CO2. 1:07:14 So it's that whole cycle needs to be at optimum levels. 1:07:18 So yeah, there's going to be a 1:07:20 there will be a consumer version. 1:07:22 Yeah. This is very exciting. 1:07:24 Thank you so much. I really appreciate your time guys. 1:07:26 Thank you doctor. Doctor, Thank you. Our pleasure. 1:07:29 Thank you, thank you. Okay.
Comments